Johnson & Johnson Expands Recall of Tylenol Arthritis Caplets


The U.S. Food and Drug Administration announced on its MedWatch site Monday that Johnson & Johnson (JNJ) is expanding a voluntary recall of Tylenol Arthritis Caplets following consumer reports of nausea and stomach pain.

The announcement came 10 days after McNeil Consumer Healthcare, the division of Johnson & Johnson that sells Tylenol products, issued a press release announcing the recall. The FDA said it would have posted the information on its site earlier, but it had thought the company's announcement would suffice in getting the word out to consumers and health care providers. %%DynaPub-Enhancement class="enhancement contentType-HTML Content fragmentId-1 payloadId-61603 alignment-right size-small"%%

Originally published